British Society of Blood and Marrow Transplantation and Cellular Therapy

an organisation for those with a professional interest in haematopoietic cell transplantation and cellular therapies

BENCHMARKING STUDIES

Historically the BSBMTCT Executive Committee have periodically requested benchmarking studies be conducted.  The Benchmarking studies were almost always retrospective and mandatory for the BSBMTCT 50 member centres and were designed to ascertain whether the outcomes were comparable with those of the European EBMT membership.

YearPrinciple InvestigatorBSBMTCT CTC Study NumberTitle
2017Karl Peggs Steve RobbinsonUK v EU 07The outcome of Allogeneic stem cell transplantation in patients with follicular lymphoma. A benchmarking analysis with European transplant outcomes 2006-2012
2014Jenny ByrneUK v EU 06The outcome of Allogeneic stem cell transplantation in patients with AML in 2nd CR: A benchmarking analysis with European transplant outcomes 2006-2011
2013David EdwardsUK v EU 05The outcome of Autologous stem cell transplantation in patients with NHL and age greater than 60:A benchmarking analysis with European transplant outcomes and an analysis of patient and disease specific factors
2011Gordon CookUK v EU 04The outcome of allogeneic stem cell transplantation in patients with Myelodysplasia: A benchmarking analysis with European transplant outcomes and an analysis of patient and disease specific factors

This practice is under review and may change in the future however, all previous studies have been published and are available to view on the publications area of the BSBMTCT website: https://bsbmtct.org/publications/

Platinum Corporate Member

For a list of our gold, silver and bronze corporate members,

click here
© 2026 British Society of Blood and Marrow Transplantation

British Society of Blood and Marrow Transplantation and Cellular Therapies
Guy's Hospital, Great Maze Pond London.
SE1 9RT United Kingdom

The BSBMTCT is not responsible for the content of external sites

Top